Abstract

Molybdenum cofactor (Moco) biosynthesis is a highly conserved multistep pathway. The first step, the conversion of GTP to cyclic pyranopterin monophosphate (cPMP), requires the bicistronic gene molybdenum cofactor synthesis 1 (MOCS1). Alternative splicing of MOCS1 within exons 1 and 9 produces four different N-terminal and three different C-terminal products (type I-III). Type I splicing results in bicistronic transcripts with two open reading frames, of which only the first, MOCS1A, is translated, whereas type II/III splicing produces MOCS1AB proteins. Here, we first report the cellular localization of alternatively spliced human MOCS1 proteins. Using fluorescence microscopy, fluorescence spectroscopy, and cell fractionation experiments, we found that depending on the alternative splicing of exon 1, type I splice variants (MOCS1A) either localize to the mitochondrial matrix (exon 1a) or remain cytosolic (exon 1b). MOCS1A proteins required exon 1a for mitochondrial translocation, but fluorescence microscopy of MOCS1AB variants (types II and III) revealed that they were targeted to mitochondria independently of exon 1 splicing. In the latter case, cell fractionation experiments displayed that mitochondrial matrix import was facilitated via an internal motif overriding the N-terminal targeting signal. Within mitochondria, MOCS1AB underwent proteolytic cleavage resulting in mitochondrial matrix localization of the MOCS1B domain. In conclusion, MOCS1 produces two functional proteins, MOCS1A and MOCS1B, which follow different translocation routes before mitochondrial matrix import for cPMP biosynthesis involving both proteins. MOCS1 protein maturation provides a novel alternative splicing mechanism that ensures the coordinated mitochondrial targeting of two functionally related proteins encoded by a single gene.

Highlights

  • Molybdenum cofactor (Moco) biosynthesis is a highly conserved multistep pathway

  • Moco biosynthesis is divided into three major steps, starting with GTP followed by the synthesis of three intermediates: cyclic pyranopterin monophosphate (cPMP) [5], molybdopterin or metal-binding pterin (MPT) [2], and adenylated MPT [6]

  • The first and most complex reaction sequence is catalyzed by two proteins in bacteria (MoaA and MoaC) whereas in humans different translation products originating from different open reading frames (ORFs) of the molybdenum cofactor synthesis 1 (MOCS1) gene are required for cPMP synthesis [7,8,9]

Read more

Summary

The abbreviations used are

Molybdenum cofactor; cPMP, cyclic pyranopterin monophosphate; MPT, metal-binding pterin; MPP, mitochondrial processing peptidase; MOCS, molybdenum cofactor synthesis. Exons (Fig. 1A) leading to different alternatively spliced MOCS1 transcripts [15]. Type II and III transcripts are derived from two alternative splice sites within exon 9, both resulting in the lack of the MOCS1A stop codon and an in-frame-fusion with the second ORF (MOCS1B), producing a monocistronic transcript. Alternative splicing of exon 9 determines whether translation products function as MOCS1A or MOCS1B proteins. MOCS1-ad and MOCS1-bcd transcripts were found in different tissues, and expression levels of MOCS1-bd were found to be very low [18] Compared with their bacterial orthologues, human MOCS1 proteins exhibit exon 1 encoded N-terminal extensions of up to 56 residues depending on the length of the N-terminal splicing product of MOCS1. Additional sub-mitochondrial localization studies of the MOCS1AB proteins revealed that only the proteolytic MOCS1B cleavage product was imported into the mitochondrial matrix, and full-length MOCS1AB could only be witnessed on the outer mitochondrial membrane

Results
Discussion
Experimental procedures
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call